Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia.
about
G-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingImaging: guiding the clinical translation of cardiac stem cell therapyNew Delivery Systems of Stem Cells for Vascular Regeneration in IschemiaThree-Dimensional Vascular Network Assembly From Diabetic Patient-Derived Induced Pluripotent Stem Cells.nAChRs mediate human embryonic stem cell-derived endothelial cells: proliferation, apoptosis, and angiogenesisEmbryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion.VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering.Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell functionGenetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles.Correlation of CD34+ cells with tissue angiogenesis after traumatic brain injury in a rat model.Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease.Isolation and characterization of novel murine epiphysis derived mesenchymal stem cells.Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspective.Efficacy of microneedling plus human stem cell conditioned medium for skin rejuvenation: a randomized, controlled, blinded split-face studyDifferentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony-forming cellsTLR2 and TLR4 mediate differential responses to limb ischemia through MyD88-dependent and independent pathwaysSkin rejuvenation by microneedle fractional radiofrequency and a human stem cell conditioned medium in Asian skin: a randomized controlled investigator blinded split-face study.Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.Interaction of a specific population of human embryonic stem cell-derived progenitor cells with CD11b+ cells ameliorates sepsis-induced lung inflammatory injury.Development of a xeno-free autologous culture system for endothelial progenitor cells derived from human umbilical cord blood.Pathogen sensing pathways in human embryonic stem cell derived-endothelial cells: role of NOD1 receptors.Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism.Three-dimensional cell grafting enhances the angiogenic efficacy of human umbilical vein endothelial cells.Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair.Engineering Strategies for the Formation of Embryoid Bodies from Human Pluripotent Stem Cells.Therapeutic angiogenesis using genetically engineered human endothelial cells.Genetically modified human placenta‑derived mesenchymal stem cells with FGF‑2 and PDGF‑BB enhance neovascularization in a model of hindlimb ischemiaAttenuation of limb loss in an experimentally induced hindlimb ischemic model by fibroblast growth factor-2/fragmin/protamine microparticles as a delivery systemRepair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity.Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells.Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cellsHuman induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneityStem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.Therapeutic transdifferentiation of human fibroblasts into endothelial cells using forced expression of lineage-specific transcription factors.Enhanced hemangioblast generation and improved vascular repair and regeneration from embryonic stem cells by defined transcription factorsPhotodynamic Approach for Teratoma-Free Pluripotent Stem Cell Therapy Using CDy1 and Visible LightTransplantation of human embryonic stem cell-derived endothelial cells for vascular diseases.Potential use of endothelial progenitor cells for regeneration of the vasculature.Vascular regeneration: engineering the stem cell microenvironment.An upregulation in the expression of vanilloid transient potential channels 2 enhances hypotonicity-induced cytosolic Ca²⁺ rise in human induced pluripotent stem cell model of Hutchinson-Gillford Progeria.
P2860
Q26772221-C2028B6B-E906-440C-AF12-A8573439143FQ27008410-B748D9FE-6DA0-4CE3-8531-B7471F01A26FQ30361288-377845D2-C572-4B8A-8D10-19DB81CF820DQ30667815-B83C77AB-B43D-450F-8F0C-1BA831FFA69FQ33503262-2CA4A55C-E6CC-46DE-8378-701AFD5749C6Q33532341-734E35FB-9D32-4DE6-8848-921A7F38B3BDQ33622516-C42A0B49-061C-455D-87D8-3BCFDC2655F1Q33726792-A437A2E3-AEDA-4796-98C4-53F5167871E9Q33734413-9B68BC41-05FC-4661-8BE1-6F4D959431A7Q33772569-8CDF819B-F306-4F3A-B31B-27BCF5E9079BQ33991356-8E193723-5A5A-443C-9340-F29DC428B2E8Q34257138-39CF751C-1A34-4DAF-9F79-EFDBF0802F5BQ34306425-A0C2F789-21AC-49EE-8B8B-690677384751Q34345902-F48C9B83-59D3-40AE-9C86-C5821DE388A1Q34443020-30948E00-2E5B-4E80-BBFE-2E4942CD8FCCQ34500561-3A824F37-9B9F-44E4-AE1A-D764F41F856DQ34569487-73881393-BFCB-443A-A1BD-A4BA33B9BD5EQ34614528-5C960F57-D315-40FE-9A58-52BB993B763EQ34756250-2588C622-E887-468F-AE74-CDE938D4F23FQ35005455-930F263D-E6CD-4458-A336-48E77B05207FQ35137398-68E5CA3A-8769-430A-BA60-965511A7F45BQ35237250-21FFFCDE-2388-4D6D-8AAA-97D9A6D5784FQ35706345-C8A85515-9F69-44BC-9281-A8F326E41C9CQ35727546-7C147804-24A3-4E52-A094-70011631C6D5Q35844417-E9F10A41-EB54-493D-88E6-D9024E1B7CB8Q36024322-08B0FEA3-9F69-44E6-B25B-9411E3D71326Q36089708-8364F76F-7E76-40D2-98AD-733EB24020C2Q36352469-CD9A949B-B812-4A3A-989F-77280F48CDC2Q36379371-971B6FC9-F55C-4EDA-8265-7C242E290EC8Q36484426-F1060D4A-DD68-4C69-B26D-C59153B3832BQ36565384-402AF528-E564-4F65-A598-C5324926EF46Q36576514-8C389CF4-8378-41F0-ACCC-B24762F46087Q36699597-93AAE456-AD03-4304-A2DD-F35F097B3104Q36763097-EE8A863E-9D67-4DB6-925A-E3D8AE5CD505Q37133650-0B34A2B5-09D4-4D5E-B6EE-3F67424A7660Q37299031-A27AF03C-102A-4C2D-A6E1-F86D744F038CQ37355158-56CB7F98-D4A4-4A97-BB34-DC5EAA790D32Q37368684-410E475B-AA77-4CC1-BA05-84DA7EAD3E4FQ37479819-D83626C3-EFE4-4DE4-A8A8-C4496EFDFF38Q37521095-BF583B1D-000D-4832-94B6-35E8EF46032D
P2860
Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Improvement of postnatal neova ...... se model of hindlimb ischemia.
@ast
Improvement of postnatal neova ...... se model of hindlimb ischemia.
@en
Improvement of postnatal neova ...... se model of hindlimb ischemia.
@nl
type
label
Improvement of postnatal neova ...... se model of hindlimb ischemia.
@ast
Improvement of postnatal neova ...... se model of hindlimb ischemia.
@en
Improvement of postnatal neova ...... se model of hindlimb ischemia.
@nl
prefLabel
Improvement of postnatal neova ...... se model of hindlimb ischemia.
@ast
Improvement of postnatal neova ...... se model of hindlimb ischemia.
@en
Improvement of postnatal neova ...... se model of hindlimb ischemia.
@nl
P2093
P1433
P1476
Improvement of postnatal neova ...... se model of hindlimb ischemia.
@en
P2093
Byung-Soo Kim
Hyo-Soo Kim
Hyung-Min Chung
Jae Min Lim
Seung-Woo Cho
Soo-Hong Lee
Sun-Woong Kang
Sung-Hwan Moon
P304
P356
10.1161/CIRCULATIONAHA.106.687038
P407
P577
2007-11-05T00:00:00Z